Catalyst Wire Dossier Catalyst Wire Dossier

insulin aspart 30 premixed (biphasic)

insulin aspart 30 · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for insulin aspart 30 premixed (biphasic), covering 2016-03-07 to 2016-03-07. Get the full timeline:

Most recent: Clinical Trial Update: Prandial Orientated Biphasic Insulin Aspart 30 Therapy - the Physiological Premix Insulin Therapy for Type 2 Diabetes

See pricing